Nucleic Acids Res · 2020
TIMER2.0 for analysis of tumor-infiltrating immune cells
Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS.
Show affiliations
- Li T — State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Chinese Academy of Medical Sciences Research Unit of Oral Carcinogenesis and Management, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, China.
- Fu J — Department of Data Sciences, Dana Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, MA 02215, USA.
- Zeng Z — Department of Data Sciences, Dana Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, MA 02215, USA.
- Cohen D — Department of Data Sciences, Dana Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, MA 02215, USA.
- Li J — State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Chinese Academy of Medical Sciences Research Unit of Oral Carcinogenesis and Management, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, China.
- Chen Q — State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Chinese Academy of Medical Sciences Research Unit of Oral Carcinogenesis and Management, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, China.
- Li B — Lyda Hill Department of Bioinformatics, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Liu XS — Department of Data Sciences, Dana Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, MA 02215, USA.
53 read7 want to readRigor 3.1Novelty 2.7Impact 3.1Reprod. 3.0
Most-cited papers citing this
- J Immunother Cancer · 2026 · cited by 2
- Mol Cancer Ther · 2026 · cited by 1
- Naunyn Schmiedebergs Arch Pharmacol · 2026 · cited by 1
- Br J Pharmacol · 2026 · cited by 1
- Front Immunol · 2026 · cited by 1
Log in to like, log, and share thoughts on this paper.
Discussion
Share your thoughts above to start a thread. Constructive feedback only — reply to and like others’ posts.
0
0
0
0
0
0
0
0
0
0
0
0
0